{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-23-014119","form_type":"8-K/A","ticker":"CRBP","cik":"0001595097","company_name":"Corbus Pharmaceuticals Holdings, Inc.","filed_at":"2023-04-24T23:59:59+00:00","discovered_at":"2026-05-14T18:03:39.578376+00:00","generated_at":"2026-06-16T18:55:41.311399+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Corbus discloses COO Craig Millian's separation terms: $445,630 severance over 12 months","bullets":["Craig Millian resigned as COO; separation date April 14, 2023; agreement signed April 24, 2023.","Severance includes $445,630 aggregate payment over 12 months plus COBRA premium reimbursement for 12 months.","If a Change in Control occurs within 3 months of separation, severance extends to 18 months of base salary + COBRA.","Stock option exercise period extended to 18 months from separation date.","Agreement includes general release, cooperation, and non-disclosure obligations."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-23-014119","json":"https://secwatch.observer/filing/0000950170-23-014119.json","markdown":"https://secwatch.observer/filing/0000950170-23-014119.md","text":"https://secwatch.observer/filing/0000950170-23-014119.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1595097/000095017023014119/0000950170-23-014119-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1595097/000095017023014119/crbp-20230303.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-16T18:55:41.311399+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"b34af0b478","claim":"Craig Millian resigned as Chief Operating Officer at Corbus Pharmaceuticals Holdings, Inc..","evidence_excerpt":"On April 24, 2023, Mr. Millian and the Company entered into a Separation and General Release Agreement (the “Separation Agreement”) related to Mr. Millian’s resignation as Chief Operating Officer from the Company.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1595097/000095017023014119/0000950170-23-014119-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Chief Operating Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}